Press "Enter" to skip to content

New patent for Purdue Pharma drug HYSINGLA

0
Copyright © DrugPatentWatch. Originally published at New patent for Purdue Pharma drug HYSINGLA

Annual Drug Patent Expirations for HYSINGLA
Annual Drug Patent Expirations for HYSINGLA

Hysingla is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from one supplier. There are thirty-six patents protecting this drug and two Paragraph IV challenges.

Drug patent litigation for HYSINGLA.

This drug has four hundred and eigthy-four patent family members in forty-eight countries.

The generic ingredient in HYSINGLA is hydrocodone bitartrate. One supplier is listed for this compound. Additional details are available on the hydrocodone bitartrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Purdue Pharma drug HYSINGLA
    Do NOT follow this link or you will be banned from the site!